Connect with others who understand.

Sign up Log in
Resources
About MyVitiligoTeam
Powered By
SPONSORED IN PART BY INCYTE ?

7 Things You Should Know About Vitiligo Clinical Trials

Updated on October 31, 2024

Enter Cell 2 Content Here...

Enter Cell 3 Content Here...

Enter Cell 4 Content Here...

Enter Cell 5 Content Here...

Enter Cell 6 Content Here...

Clinical trials are very important for finding safe and effective treatments for vitiligo.1 While there are some treatment options for vitiligo, it can still be hard to treat.2 People with vitiligo may be eligible to participate in a clinical trial, helping scientists study new investigational treatments for vitiligo and learn more about the condition.1

If you’re thinking about joining a clinical trial for vitiligo, here are seven things you should know.

1. A Clinical Research Program Typically Has Four Phases

The steps of a research programs are called phases.1

Phase 1

A phase 1 clinical trial focuses on safety and side effects on a few people. It may include people with or without the condition being studied.1

Phase 2

A phase 2 clinical trial tests the treatment on more people with the condition to check its safety and effectiveness. Sometimes, several hundred people with a condition will participate in this phase.1

Phase 3

A phase 3 clinical trial aims at confirming the treatment’s safety and effectiveness in patients with the condition. This is the last phase before potential U.S. Food and Drug Administration (FDA) approval. These are very large studies with hundreds — sometimes thousands — of participants.3

FDA Approval

After phase 3, the results of the clinical trial are reviewed by the FDA. If the FDA finds that the treatment is safe and effective, it’s approved for use by health care providers for the condition it was tested for in the trials.3

After phase 3, the results of the clinical trial are reviewed by the FDA.

Enter Cell 2 Content Here...

Enter Cell 3 Content Here...

Enter Cell 4 Content Here...

Enter Cell 5 Content Here...

Enter Cell 6 Content Here...

Phase 4

Once approved, the treatment is available to people with the condition. During a phase 4 clinical trial, researchers continue studying long-term effects in real-world situations. Usually, these are very large studies with thousands of participants.1,3

2. Treatments Are Tested Before Clinical Trials

Before a clinical trial, an investigational drug or device is studied in the laboratory to check its safety and effectiveness.4 If it passes these tests, the FDA approves it for trials with humans.3

3. Safety Is a Priority

Each country has rules for approving clinical trial designs. In the U.S., a clinical trial protocol outlines how study participants will be protected from risks.1 The FDA requires most studies to be reviewed by an Institutional Review Board (or IRB), which protects the well-being and rights of volunteers.5 Clinical trials may also have other committees that monitor the safety of volunteers during a study.5

4. You Will Know the Details Before Joining

Before you join a clinical trial, you’ll get detailed information about it, including possible risks and what will happen during the trial. This process, called “informed consent,” gives you the opportunity to discuss the trial with your health care provider and family and ask questions.5

Informed consent gives you the opportunity to discuss the trial with your health care provider and family and ask questions.

Enter Cell 2 Content Here...

Enter Cell 3 Content Here...

Enter Cell 4 Content Here...

Enter Cell 5 Content Here...

Enter Cell 6 Content Here...

5. Placebo May Be Used in a Clinical Trial

In some trials, you’ll receive a placebo (a substance that looks like the investigational drug but has no medicine in it).5 This helps researchers compare it to the investigational treatment they’re studying.5

Clinical trials often have a group of people who get the placebo and a group of people who get the real investigational treatment. This group is chosen randomly, and neither the participant nor the researcher knows who is getting the placebo. Even if you get the placebo, you might still get the real investigational treatment for your condition along with the placebo.5

Sometimes, after the phase 3 trial ends, you might get asked to join another study called an extension study. An extension study gathers more information about the treatment’s safety and effectiveness.6

6. Investigational Drugs Have Risks

Every drug, including those in clinical trials, can have side effects. Before joining a clinical trial, you’ll be told about possible risks and side effects.5 It’s also possible that the investigational treatment may not work.5

Before joining a clinical trial, you’ll be told about possible risks and side effects.

Enter Cell 2 Content Here...

Enter Cell 3 Content Here...

Enter Cell 4 Content Here...

Enter Cell 5 Content Here...

Enter Cell 6 Content Here...

7. Joining a Clinical Trial Is Voluntary

Joining a clinical trial is 100 percent voluntary, and you can leave at any time.5

Talk With Others Who Understand

MyVitiligoTeam is the social network for people with vitiligo and their loved ones. Here, over 13,000 members come together to ask questions, offer support and advice, and meet others who understand life with vitiligo.

Do you have questions about clinical trials for vitiligo and how they work? Share your thoughts in the comments below or by posting on your Activities page.

References
  1. NIH clinical research trials and you: the basics. National Institutes of Health. Updated October 3, 2022. Accessed May 6, 2024. https://www.nih.gov/health-information/nih-clinical-research-trials-you/basics
  2. Seong SH, Oh SH. Up-and-coming drugs for the treatment of vitiligo. Ann Dermatol. 2024;36(4):197-208. doi:10.5021/ad.24.038
  3. What are clinical trials and studies? National Institute on Aging. Updated March 22, 2023. Accessed May 6, 2024. https://www.nia.nih.gov/health/clinical-trials-and-studies/what-are-clinical-trials-and-studies
  4. Step 2: preclinical research. U.S. Food and Drug Administration. Updated January 4, 2018. Accessed May 6, 2024. https://www.fda.gov/patients/drug-development-process/step-2-preclinical-research
  5. Clinical research: benefits, risks, and safety. National Institute on Aging. Updated May 18, 2023. Accessed May 6, 2024. https://www.nia.nih.gov/health/clinical-trials-and-studies/clinical-research-benefits-risks-and-safety
  6. Burcu M, Manzano-Salgado CB, Butler AM, Christian JB. A framework for extension studies using real-world data to examine long-term safety and effectiveness. Ther Innov Regul Sci. 2022;56(1):15-22. doi:10.1007/s43441-021-00322-8

Updated on October 31, 2024

A MyVitiligoTeam Member

Action not just words

May 31, 2022
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
Elizabeth Wartella, M.P.H. is an Editor at MyHealthTeam. She holds a Master's in Public Health from Columbia University and is passionate about spreading accurate, evidence-based health information. Learn more about her here.

Thank you for subscribing!

Become a member to get even more: